highly significantp < 0.0001
OMP treatment reduced TGF-β1 levels to 180.7 ± 2.82 pg/mg protein, whereas GLY-NPs dropped it further, to 90.83 ± 2.41 pg/mg protein, with all intergroup comparisons being highly significant ( p < 0.0001) ( Figure 8 A).
OMP treatment reduced TGF-β1 levels to 180.7 ± 2.82 pg/mg protein, whereas GLY-NPs dropped it further, to 90.83 ± 2.41 pg/mg protein, with all intergroup comparisons being highly significant ( p < 0.0001) ( Figure 8 A).